17:32 , Jan 11, 2019 |  BC Week In Review  |  Financial News

InnoCare raises $160M to advance Btk inhibitor

InnoCare Pharma Ltd. (Beijing, China) said on Jan. 4 that it raised $160 million in a venture round led by Loyal Valley Capital with participation from 3H Health Investment, Epiphron Capital Fund II and existing...
22:20 , Jan 4, 2019 |  BC Extra  |  Financial News

InnoCare raises $160M to advance Btk inhibitor

InnoCare Pharma Ltd. (Beijing, China) said Friday that it raised $160 million in a venture round led by Loyal Valley Capital with participation from 3H Health Investment, Epiphron Capital Fund II and existing investors Vivo...